找到约 20 条 “PH-002” 相关结果 （用时 0.106 秒）
| 目录号 | 产品名称 | 中文名称 | 靶点 |
|---|---|---|---|
M8351
|
PH-002 | PH-002 | Others |
| PH-002是神经元细胞中载脂蛋白（apo）E4分子域内相互作用的抑制剂，可恢复线粒体细胞色素c氧化酶亚单位1的水平，降低线粒体运动损伤。 | |||
| M11795 | ChemBridge-5190027 | ChemBridge化合物-5190027 | Screening Compounds and Building Blocks |
| 4-phenyl-1,3-dihydro-2H-naphtho[2,3-b][1,4]diazepin-2-one (5190027) | |||
| ChemBridge特有类药化合物/先导化合物-5190027，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M12166 | ChemBridge-5570026 | ChemBridge化合物-5570026 | Screening Compounds and Building Blocks |
| 4-nitrophenyl 4-{[amino(imino)methyl]amino}benzoate hydrochloride (5570026) | |||
| ChemBridge特有类药化合物/先导化合物-5570026，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M12599 | ChemBridge-6160027 | ChemBridge化合物-6160027 | Screening Compounds and Building Blocks |
| 3,3'-[(3-fluorophenyl)methylene]bis(4-hydroxy-2H-chromen-2-one) (6160027) | |||
| ChemBridge特有类药化合物/先导化合物-6160027，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M12794 | ChemBridge-6860025 | ChemBridge化合物-6860025 | Screening Compounds and Building Blocks |
| 4-({3-[4-oxo-5-(3-phenyl-2-propen-1-ylidene)-2-thioxo-1,3-thiazolidin-3-yl]propanoyl}amino)benzoic acid (6860025) | |||
| ChemBridge特有类药化合物/先导化合物-6860025，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M12803 | ChemBridge-6877002 | ChemBridge化合物-6877002 | Screening Compounds and Building Blocks |
| 3-[(2,5-dimethylphenyl)amino]-1-phenyl-2-propen-1-one (6877002) | |||
| ChemBridge特有类药化合物/先导化合物-6877002，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M45403 | ChemBridge-4002385 | ChemBridge化合物-4002385 | Screening Compounds and Building Blocks |
| N,N-dimethyl-1-[4-(2-piperidinyl)phenyl]methanamine dihydrochloride (4002385) | |||
| ChemBridge特有类药化合物/先导化合物-4002385，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M45689 | ChemBridge-5752002 | ChemBridge化合物-5752002 | Screening Compounds and Building Blocks |
| 4-(4-fluorophenyl)-6-methyl-N-(2-methylphenyl)-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxamide (5752002) | |||
| ChemBridge特有类药化合物/先导化合物-5752002，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M46043 | ChemBridge-7002101 | ChemBridge化合物-7002101 | Screening Compounds and Building Blocks |
| N-{2-[2-(4-tert-butyl-2-methylphenoxy)ethoxy]ethyl}-1-butanamine oxalate (7002101) | |||
| ChemBridge特有类药化合物/先导化合物-7002101，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M46227 | ChemBridge-7698002 | ChemBridge化合物-7698002 | Screening Compounds and Building Blocks |
| 1-[3-(1H-1,2,3-benzotriazol-1-ylmethyl)-4-methoxyphenyl]-2,3,4,9-tetrahydro-1H-beta-carboline-3-carboxylic acid (7698002) | |||
| ChemBridge特有类药化合物/先导化合物-7698002，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M46594 | ChemBridge-8830028 | ChemBridge化合物-8830028 | Screening Compounds and Building Blocks |
| N-(3-acetylphenyl)-N'-(4-fluorobenzyl)thiourea (8830028) | |||
| ChemBridge特有类药化合物/先导化合物-8830028，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M46681 | ChemBridge-8900247 | ChemBridge化合物-8900247 | Screening Compounds and Building Blocks |
| N-(1-methyl-1H-benzimidazol-2-yl)-5-(1-naphthyl)-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide (8900247) | |||
| ChemBridge特有类药化合物/先导化合物-8900247，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M46743 | ChemBridge-9002061 | ChemBridge化合物-9002061 | Screening Compounds and Building Blocks |
| N-(2-hydroxyphenyl)-2-[(6-oxo-4-phenyl-1,6-dihydro-2-pyrimidinyl)thio]acetamide (9002061) | |||
| ChemBridge特有类药化合物/先导化合物-9002061，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M47641 | ChemBridge-24704002 | ChemBridge化合物-24704002 | Screening Compounds and Building Blocks |
| N-[4-(1-phenyl-1H-pyrazol-4-yl)-2-pyrimidinyl]-1,5-pentanediamine trifluoroacetate (24704002) | |||
| ChemBridge特有类药化合物/先导化合物-24704002，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M47847 | ChemBridge-33002714 | ChemBridge化合物-33002714 | Screening Compounds and Building Blocks |
| 3-(5-{[3-(3-methoxyphenyl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl]methyl}-3-thienyl)-2-propyn-1-ol (33002714) | |||
| ChemBridge特有类药化合物/先导化合物-33002714，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M48551 | ChemBridge-62002482 | ChemBridge化合物-62002482 | Screening Compounds and Building Blocks |
| N-[1-(3,5-difluorophenyl)-4,5,6,7-tetrahydro-1H-indazol-4-yl]-2-butynamide (62002482) | |||
| ChemBridge特有类药化合物/先导化合物-62002482，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M48594 | ChemBridge-63790027 | ChemBridge化合物-63790027 | Screening Compounds and Building Blocks |
| 2,4-dichloro-3-(1-pyrrolidinylmethyl)phenol (63790027) | |||
| ChemBridge特有类药化合物/先导化合物-63790027，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M49001 | ChemBridge-83450024 | ChemBridge化合物-83450024 | Screening Compounds and Building Blocks |
| 2-[1-(2-phenylethyl)-5-tetrazolo[1,5-a]pyridin-7-yl-1H-1,2,4-triazol-3-yl]acetamide (83450024) | |||
| ChemBridge特有类药化合物/先导化合物-83450024，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M49140 | ChemBridge-90027791 | ChemBridge化合物-90027791 | Screening Compounds and Building Blocks |
| 1-(2-fluorobenzyl)-N-(3'-methoxy-2-biphenylyl)-4-piperidinecarboxamide (90027791) | |||
| ChemBridge特有类药化合物/先导化合物-90027791，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M14486 | BN82002 hydrochloride | BN82002 hydrochloride | Phosphatase |
| BN82002 hydrochloride 是 CDC25 phosphatase 家族的有效，选择性和不可逆的泛抑制剂。 BN82002 hydrochloride抑制 CDC25A，CDC25B2，CDC25B3，CDC25C CDC25A 和 25C-cat 的 IC50 值分别为 2.4、3.9、6.3、5.4 和 4.6 µM。 BN82002 hydrochloride 显示出比 CD45 酪氨酸磷酸酶高约 20 倍的选择性。 | |||
